Rep. Jennifer Conlin

Maddy summaryHB 4546 requires health insurers in Michigan providing prescription drug coverage to comply with Section 12 of the Prescription Drug Cost and Affordability Review Act. This bill directly affects health insurance companies operating in Michigan that offer prescription drug benefits. The key provision mandates these insurers to follow specific cost and affordability review requirements already established under the Review Act. The bill is tied to companion legislation (HB 4544) and is currently pending in the House Committee on Government Operations.

Maddy summaryHB 4545 requires Michigan's medical assistance program to comply with Section 12 of the Prescription Drug Cost and Affordability Review Act. This bill directly affects low-income residents enrolled in Michigan's medical assistance program by mandating adherence to state drug cost review requirements. The key provision adds Section 109o to Michigan's Social Welfare Act, making compliance with the drug cost review act a program requirement. The bill is conditional, stating it will not take effect unless companion legislation (HB 4544) is enacted into law. The bill was introduced on June 3, 2025, and referred to the Government Operations Committee.

Maddy summaryHB 4544 creates Michigan's Prescription Drug Affordability Board and Stakeholder Council to review and set price limits for prescription drugs. The Board will establish upper payment limits for brand-name, generic, biologic, and biosimilar drugs, requiring manufacturers to justify price increases above the Consumer Price Index. This directly affects drug manufacturers, health insurers, pharmacy benefit managers, and patients by limiting how much they can charge for covered medications. The law aims to improve drug affordability through state oversight, with the Board required to conduct annual reviews and set rules for pricing.

Maddy summaryHB 4267 designates a specific segment of M-6 in Kent County (from Kalamazoo Avenue east to 60th Street) as the "Keagan Spencer Memorial Highway" under Michigan's Memorial Highway Act. This bill is purely a naming designation with no policy changes or direct impact on legislation, regulations, or affected populations. It amends the existing highway act to formally recognize this roadway section in honor of Keagan Spencer. The bill passed unanimously in the Michigan House on May 20, 2025.

Maddy summaryHouse Resolution 115 is a resolution from the Michigan House of Representatives that urges the President and the United States Congress to fully fund Medicaid. It also calls on federal officials to reject any proposals that would reduce access to care or shift costs onto states, healthcare providers, and vulnerable individuals.

Maddy summaryHB 4038 amends Michigan's Insurance Provider Assessment Act to redirect funds collected from insurance companies. It specifies that money must be used for: (1) paying Medicaid managed care organizations up to $14 million annually for capitation rates; (2) offsetting lost revenue from health insurance claims assessments ($315 million for 2018-19, $240 million for 2019-20); and (3) funding a health data utility with $6 million in 2026, increasing to $8 million annually starting in 2028 (adjusted for inflation via the Consumer Price Index). The bill ensures these funds remain in a dedicated account and do not lapse to the general fund. This directly affects Medicaid providers, the state treasury, and the health data utility managing public health information.

Maddy summaryHB 4037 establishes requirements for health data utilities in Michigan, defining them as systems that securely combine and share health data for treatment, care coordination, and public health purposes. It requires the Health Information Technology Commission to develop a strategic plan addressing data standards, privacy, security, cost reduction, and patient access by 2026. The bill mandates a request for proposal process to select a Michigan-based health information exchange to operate this utility by March 2026, directly affecting hospitals, providers, payers, and patients who interact with the state's health data systems. Key provisions include protecting patient privacy, reducing medical errors, and ensuring interoperability between health care entities.

Maddy summaryHouse Bill 4498 proposes to amend Michigan's Public Health Code to allow the Department of Health or local government agencies to authorize and establish "needle and hypodermic syringe access programs." These programs aim to reduce the spread of communicable diseases by providing sterile needles and syringes, as well as other related items. Individuals participating in these authorized programs would be exempt from criminal penalties for possessing or distributing needles, syringes, drug paraphernalia, trace amounts of controlled substances in used equipment, or drug testing equipment. The bill amends sections 7401 and 7403 of the Public Health Code to incorporate these new exemptions.

Maddy summaryHB 4497 amends Michigan's Public Health Code to modify the legal definition of "drug paraphernalia." The bill establishes that "drug paraphernalia" does not include testing products used to determine if a controlled substance contains harmful chemicals, toxic substances, or hazardous compounds that could cause physical harm or death. This specifically includes items like fentanyl testing strips. This change affects individuals who possess or use such testing products, clarifying their legal status under the law.

Maddy summaryHouse Bill 4500 establishes a grant program for a research institution to conduct a pilot program in Michigan. This program aims to assess the levels of PFAS (per- and polyfluoroalkyl substances) in the blood of qualified participants and study their health effects. A dedicated PFAS pilot program fund will be created to cover grants, blood testing, and the development of educational materials. The Department of Health will oversee the program, select the research institution, and submit reports to the legislature on the program's findings and recommendations.